The Relationship Between Serum Asymmetric Dimethylarginine Levels and Cardiovascular Risk Factors in Children with Nephrotic Syndrome

The Relationship Between Serum Asymmetric Dimethylarginine Levels and Cardiovascular Risk Factors in Children with Nephrotic Syndrome

Aim:Nephrotic syndrome is a common type of kidney disease during childhood characterized by proteinuria, edema and hypoalbuminemia. Serum asymmetric dimethylarginine (ADMA) inhibits vascular nitric oxide production and may be an independent risk factor for coronary heart disease. The aim of this stu...

Full description

Bibliographic Details
Main Authors:	Bağdagül Aksu, Sevinç Emre, Alev Yılmaz, Zeynep Nagehan Yürük, Ümit Dilber Mutlu Demirel, Oğuz Bülent Erol, Cemile Pehlivanoğlu
Format:	Article
Language:	English
Published:	Galenos Yayinevi 2019-06-01
Series:	Haseki Tıp Bülteni
Subjects:	Nephrotic syndrome children atherosclerosis asymmetric dimethylarginine carotid intima-media thickness
Online Access:	http://www.hasekidergisi.com/archives/archive-detail/article-preview/the-relationship-between-serum-asymmetric-dimethyl/26204

Similar Items

Evaluation of carotid intima media thickness in children with idiopathic nephrotic syndrome
by: Ashraf Sayed Kamel, et al.
Published: (2022-12-01)

The association between coronary atherosclerotic burden and asymmetric dimethylarginine, carotis intima media thickness and endothelial function
by: Fatma Can, et al.
Published: (2014-12-01)

Asymmetric Dimethylarginine: Clinical Applications in Pediatric Medicine
by: You-Lin Tain, et al.
Published: (2011-02-01)

Comparison of two methods for dimethylarginines quantification
by: Vendula Sudová, et al.
Published: (2024-03-01)

Toxic Dimethylarginines: Asymmetric Dimethylarginine (ADMA) and Symmetric Dimethylarginine (SDMA)
by: You‐Lin Tain, et al.
Published: (2017-03-01)

Symmetrical (SDMA) and asymmetrical dimethylarginine (ADMA) in sepsis: high plasma levels as combined risk markers for sepsis survival
by: Martin Sebastian Winkler, et al.
Published: (2018-09-01)

Association of dimethylarginines and mediators of inflammation after acute ischemic stroke
by: Chen Shufen, et al.
Published: (2012-11-01)

The relationship of asymmetric dimethylarginine levels with uncontrolled arterial hypertension and hypertension disease stage
by: Aleksandr N. Stafeev, et al.
Published: (2023-11-01)

Asymmetric and Symmetric Dimethylarginines as Renal Function Parameters in Paediatric Kidney Diseases: A Literature Review from 2003 to 2022
by: Michalina Jezierska, et al.
Published: (2022-10-01)

Relationship of asymmetric dimethylarginine levels with disease severity and pulmonary hypertension in chronic obstructive pulmonary disease
by: Elif Torun Parmaksız, et al.
Published: (2018-01-01)

Association between Newly Diagnosed Essential Hypertension, Smoking, Assymetric Dimethylarginine and ischemia-Modified Albumin
by: Emine Altuntaş, et al.
Published: (2017-06-01)

Nitric Oxide Metabolites and Asymmetric Dimethylarginine Concentrations in Breast Milk
by: Hakan Öztürk, et al.
Published: (2017-04-01)

Association of Circulating Levels of ADMA with Carotid Intima-Media Thickness in Patients with CKD: a Systematic Review and Meta-Analysis
by: Fang Wang, et al.
Published: (2018-01-01)

Targeting on Asymmetric Dimethylarginine-Related Nitric Oxide-Reactive Oxygen Species Imbalance to Reprogram the Development of Hypertension
by: You-Lin Tain, et al.
Published: (2016-12-01)

The effect of haptoglobin genotype on the association of asymmetric dimethylarginine and DDAH 1 polymorphism with diabetic macroangiopathy
by: Shiyun Wang, et al.
Published: (2022-12-01)

Role of Asymmetric Dimethylarginine in Psychiatric Disorders
by: Selma Bozkurt Zincir, et al.
Published: (2014-08-01)

The relationship between serum asymmetric dimethylarginine levels and radial artery spasm
by: Ibrahim Kocayigit, et al.
Published: (2020-03-01)

Inhibitors of the Hydrolytic Enzyme Dimethylarginine Dimethylaminohydrolase (DDAH): Discovery, Synthesis and Development
by: Rhys B. Murphy, et al.
Published: (2016-05-01)

Nebivolol prevents the increase of asymmetric dimethylarginine and oxidants in hyperhomocysteinemic rats
by: Mustafa Ahmet Huyut
Published: (2019-01-01)

Determination of Asymmetric and Symmetric Dimethylarginine in Serum from Patients with Chronic Kidney Disease: UPLC-MS/MS versus ELISA
by: Jente Boelaert, et al.
Published: (2016-05-01)

Endocan and Asymmetric Dimethylarginine as an Etiological Indicator in the Maternal and Umbilical Cord Serum in Pre-Eclampsia
by: Nihal Inandiklioglu, et al.
Published: (2021-09-01)

Increased Serum Levels of Asymmetric Dimethylarginine and Symmetric Dimethylarginine and Decreased Levels of Arginine in Sudanese Patients with Essential Hypertension
by: Sahar Gamil, et al.
Published: (2020-08-01)

Asymmetric dimethylarginine as a prognostic marker for cardiovascular complications in hypertensive patients
by: Osama Tayeh, et al.
Published: (2011-06-01)

Plasmatic Dimethylarginines in Dogs With Myxomatous Mitral Valve Disease
by: Carlotta Valente, et al.
Published: (2021-09-01)

NEPHROTIC CRISIS — AN URGENT CONDITION IN PATIENTS WITH NEPHROTIC SYNDROME
by: L V Kozlovskaya, et al.
Published: (2012-06-01)

Dimethylarginines in Children after Anti-Neoplastic Treatment
by: Michalina Jezierska, et al.
Published: (2022-01-01)

ASYMMETRIC DIMETHYLARGININE, THE PROMOTER FACTOR OF CARDIOVASCULAR PATHOLOGIES
by: Anamaria Vîlcea, et al.
Published: (2019-09-01)

Serum symmetric dimethylarginine in older dogs: Reference interval and comparison of a gold standard method with the ELISA
by: Sofie Marynissen, et al.
Published: (2024-03-01)

Association of Asymmetric and Symmetric Dimethylarginine with Inflammation in the Population-Based Study of Health in Pomerania
by: Martin Sebastian Winkler, et al.
Published: (2023-11-01)

Symmetric and asymmetric dimethylarginine as risk markers of cardiovascular disease, all-cause mortality and deterioration in kidney function in persons with type 2 diabetes and microalbuminuria
by: Emilie H. Zobel, et al.
Published: (2017-07-01)

Pathophysiological Role of Adiponectin, Leptin and Asymmetric Dimethylarginine in the Process of Atherosclerosis
by: Koleva Daniela Iv., et al.
Published: (2016-12-01)

Urinary Dimethylamine (DMA) and Its Precursor Asymmetric Dimethylarginine (ADMA) in Clinical Medicine, in the Context of Nitric Oxide (NO) and Beyond
by: Dimitrios Tsikas
Published: (2020-06-01)

The influence of renin angiotensin aldosterone system blockers on asymmetric dimethylarginine levels in patients with chronic glomerulonephritis
by: Heleniak Zbigniew, et al.
Published: (2016-12-01)

High plasma concentrations of asymmetric dimethylarginine inhibit ischemic cardioprotection in hypercholesterolemic rats
by: M.B.P. Landim, et al.
Published: (2013-10-01)

Asymmetric and symmetric dimethylarginine in patients presenting with risk factors for coronary heart disease
by: Ilic Marina, et al.
Published: (2012-10-01)

Raised Plasma Levels of Asymmetric Dimethylarginine Are Associated with Pathological Type and Predict the Therapeutic Effect in Lupus Nephritis Patients Treated with Cyclophosphamide
by: Li Zhang, et al.
Published: (2020-07-01)

Serum Asymmetric Dimethylarginine Levels in Patients with Vasovagal Syncope
by: Adem Atıcı, et al.
Published: (2019-10-01)

Symmetric Dimethylarginine is a Promising Biomarker for the Early Detection of Age-Related Kidney Dysfunction in Zoo Felids
by: Youn Soong-Hee, et al.
Published: (2022-09-01)

Effect of resistance training on plasma nitric oxide and asymmetric dimethylarginine concentrations in type I diabetic rats
by: Parivash Shekarchizadeh Esfahani, et al.
Published: (2013-01-01)

Study of endothelial dysfunction and asymmetric dimethylarginine levels
by: Ya. V. Sirman, et al.
Published: (2019-10-01)